Protocols
1 protocol(s) meet the specified criteria
Drug: CRIZOTINIB
Protocol No.TitleStatus
E4512-CIRBA Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion ProteinOpen